GlaxoSmithKline
GSK
#209
Rank
โ‚น8.778 T
Marketcap
โ‚น4,349
Share price
-0.33%
Change (1 day)
53.76%
Change (1 year)

GlaxoSmithKline (GSK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น5.505 Trillion

According to GlaxoSmithKline's latest financial reports the company's total liabilities are โ‚น5.505 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

GlaxoSmithKline - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น4.992 T1.87%
2023-12-31โ‚น4.900 T-2.19%
2022-12-31โ‚น5.010 T-13.66%
2021-12-31โ‚น5.803 T-2.36%
2020-12-31โ‚น5.943 T3.63%
2019-12-31โ‚น5.735 T18.8%
2018-12-31โ‚น4.827 T5.77%
2017-12-31โ‚น4.564 T0.58%
2016-12-31โ‚น4.537 T3.39%
2015-12-31โ‚น4.389 T24.54%
2014-12-31โ‚น3.524 T0.9%
2013-12-31โ‚น3.492 T13.6%
2012-12-31โ‚น3.074 T15.94%
2011-12-31โ‚น2.651 T18.01%
2010-12-31โ‚น2.247 T-6.83%
2009-12-31โ‚น2.411 T10.17%
2008-12-31โ‚น2.189 T32.98%
2007-12-31โ‚น1.646 T19.34%
2006-12-31โ‚น1.379 T-9.42%
2005-12-31โ‚น1.522 T11.06%
2004-12-31โ‚น1.371 T8.69%
2003-12-31โ‚น1.261 T9.83%
2002-12-31โ‚น1.148 T21.01%
2001-12-31โ‚น949.24 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
โ‚น6.152 T 11.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น10.388 T 88.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.974 T 26.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.618 T 2.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น5.931 T 7.74%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚น2.928 T-46.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚น37.04 B-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA